Sebastian Bauer (medical doctor)

Sebastian Bauer (* 1973) is a German doctor and university lecturer. Since 2016 he has held the professorship for translational oncology with a focus on personalized tumor therapy at the University of Duisburg-Essen .

Life

From 1993 to 1999, Bauer studied human medicine at the Julius Maximilians University in Würzburg, where he did his doctorate in cardiology with Ludwig Neyses. He completed his specialist training as an internist as well as further training in hematology / oncology at the University Hospital Essen (S. Seeber). He completed his habilitation in 2009 on the subject of "New therapeutic approaches for soft tissue sarcoma" (Director: Martin Schuler).

Act

In his senior physician function, he heads the sarcoma focus within the internal clinic (tumor research) (Director: Martin Schuler) and is also the medical spokesman for the Sarcoma Center at the West German Tumor Center. He also heads the Translational Sarcoma Research group. He is also a member of the Advisory Board of the Sarcoma Conference .

Awards

In 2015 he received the GIST Prize of the Swiss Working Group for Clinical Cancer Research .

Publication (selection)

As a book

• Sebastian Bauer and others: Individualized therapy of sarcomas - standards and perspectives , Bremen: UNI-MED Verlag AG, 2015, ISBN 978-3-8374-1505-6

Articles in specialist journals

• Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organization for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072, in Annals of Oncology (Issue 3. 2014), ISSN  0923-7534
• Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors, in the British Journal of Cancer (Issue 4. 2014), ISSN  0007-0920
• Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma, in Human Pathology , ISSN  0046-8177
• Targeting gain of function and resistance mutations in Abl and KIT by hybrid compound design, in the Journal of Medicinal Chemistry , (July 2013), ISSN  0022-2623
• Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumor and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis, in the European Journal of Cancer , ISSN  0959-8049

Web links

• Sebastian Bauer at the University Hospital Essen

supporting documents

1. ↑ the Advisory Board members of the Sarcoma Conference (as of 2016)  ( page no longer available , search in web archives )  Info: The link was automatically marked as defective. Please check the link according to the instructions and then remove this notice.  
2. ↑ Archived copy ( Memento of the original dated August 2, 2016 in the Internet Archive ) Info: The archive link has been inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice.